Last week, a boy in Colorado picked up a used condom on his school’s playground and put it into his mouth. Though this might not seem like news, media outlets across the country, and even internationally, have focused on his risk of acquiring a sexually transmitted infection.
Because Depo-Provera is an important contraceptive choice and because in many parts of the world, it is the only long-acting, discreet option available to women, it is vital to take the issue of a link between HIV and hormonal contraception quite seriously while adding nuance to the discussion.
Many people living with HIV are often denied the autonomy to freely make decisions about their bodies, relationships, and children—fundamental rights sought by the reproductive justice movement.
An international group of researchers believe they have pinpointed not just where and when the virus emerged in people, but the “perfect storm” that helped it become a worldwide phenomenon that has infected 75 million people to date.
This week, new estimates suggest almost two million cases of chlamydia, there’s more evidence that HIV therapy cannot eradicate the virus in babies, and a study finds that less pubic hair may mean fewer pubic lice—though they won’t be extinct any time soon.
For women in countries and communities with limited contraceptive choices and high rates of HIV, particularly in sub-Saharan Africa, a shortage of funding for the ECHO (Evidence for Contraceptive Options and HIV Outcomes) trial is an unacceptable development.
Johnson, a college wrestler who’s been charged with “recklessly infecting another with HIV,” offers us a lens through which to examine how Black gay men are particularly vulnerable to HIV criminalization.
This week, LA County is reviving an at-home STI testing service, a new study shows that male circumcision can reduce rates of HIV among women as well as men, and an Australian company gets approval to produce a microbicide condom.
Contrary to some initial reports, the World Health Organization did not declare that all men who have sex with men should start taking PrEP as a means of preventing HIV. Instead, the group wants this population to work with their health-care providers to assess their personal risk and determine whether PrEP is right for them.
Doctors were devastated to announce last week that their patient, an almost 4-year-old girl was once thought “cured” of HIV, was found to have detectable viral loads and lowered T-cell counts.